Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
Clinical trial NCT02484053 · COMPLETED
Trial details
- NCT number
- NCT02484053
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.